Zepbound (tirzepatide) is an FDA-approved medication for chronic weight management that has shown promising effects on cardiovascular risk factors, including blood pressure
The medication can be considered for adults who are obese (with a BMI 30) or overweight (with a BMI 27 who also have at least one weight-related comorbid condition (ie
At Klinic's semaglutide clinic in Killeen, we focus exclusively on FDA-approved, branded medications like Wegovy and Ozempic
Combination therapies: Some trials may give us an initial understanding of potential combination approaches where GLP-1s could be combined with a monoclonal anti-amyloid treatment approved to treat Alzheimer's disease or other emerging therapies
3 Complete coverage coordination questions (other group plan coverage, whether the drug is covered/declined elsewhere, and whether benefits recently transferred to Manulife), and attach any required proof/decline notices if applicable
Whilst mild to moderate fatigue during the initial weeks of tirzepatide treatment is relatively common and often self-limiting, certain presentations warrant prompt medical evaluation
